Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation
Sign Up to like & getrecommendations! Published in 2017 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.12705
Abstract: Pulmonary vascular remodelling is a common feature among the heterogeneous disorders that cause pulmonary arterial hypertension (PAH), and pulmonary arterial smooth muscle cells (PASMCs) proliferation impact the long‐term prognosis of the patient. Isoquercitrin (IQC) is… read more here.
Keywords: vascular remodelling; iqc; proliferation; pasmcs proliferation ... See more keywords